Literature DB >> 22648633

High resolution navigated three-dimensional T₁-weighted hepatobiliary MRI using gadoxetic acid optimized for 1.5 Tesla.

Scott K Nagle1, Reed F Busse, Anja C Brau, Jean H Brittain, Alex Frydrychowicz, Yuji Iwadate, Scott B Reeder.   

Abstract

PURPOSE: To determine optimal delay times and flip angles for T1-weighted hepatobiliary imaging at 1.5 Tesla (T) with gadoxetic acid and to demonstrate the feasibility of using a high-resolution navigated optimized T1-weighted pulse sequence to evaluate biliary disease.
MATERIALS AND METHODS: Eight healthy volunteers were scanned at 1.5T using a T1-weighted three-dimensional (3D)-SPGR pulse sequence following the administration of 0.05 mmol/kg of gadoxetic acid. Navigator-gating enabled acquisition of high spatial resolution (1.2 × 1.4 × 1.8 mm(3) , interpolated to 0.7 × 0.7 × 0.9 mm(3) ) images in approximately 5 min of free-breathing. Multiple breath-held acquisitions were performed at flip angles between 15° and 45° to optimize T1 weighting. To evaluate the performance of this optimized sequence in the setting of biliary disease, the image quality and biliary excretion of 51 consecutive clinical scans performed to assess primary sclerosing cholangitis (PSC) were evaluated.
RESULTS: Optimal hepatobiliary imaging occurs at 15-25 min, using a 40° flip angle. The image quality and visualization of biliary excretion in the PSC scans were excellent, despite the decreased liver function in some patients. Visualization of reduced excretion often provided diagnostic information that was unavailable by conventional magnetic resonance cholangiopancreatography (MRCP).
CONCLUSION: High-resolution navigated 3D-SPGR hepatobiliary imaging using gadoxetic acid and optimized scan parameters is technically feasible and can be clinically useful, even in patients with decreased hepatobiliary function.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648633      PMCID: PMC3445654          DOI: 10.1002/jmri.23713

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  31 in total

1.  Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.

Authors:  A Spinazzi; V Lorusso; G Pirovano; M Kirchin
Journal:  Acad Radiol       Date:  1999-05       Impact factor: 3.173

2.  Shortening MR image acquisition time for volumetric interpolated breath-hold examination with a recently developed parallel imaging reconstruction technique: clinical feasibility.

Authors:  Charles A McKenzie; Daniel Lim; Bernard J Ransil; Martina Morrin; Ivan Pedrosa; Ernest N Yeh; Daniel K Sodickson; Neil M Rofsky
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105

3.  Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.

Authors:  Alex Frydrychowicz; Scott K Nagle; Sharon L D'Souza; Karl K Vigen; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-07-12       Impact factor: 4.813

4.  Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

Authors:  Luigi Grazioli; Giovanni Morana; Miles A Kirchin; Günther Schneider
Journal:  Radiology       Date:  2005-06-13       Impact factor: 11.105

5.  Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1.

Authors:  J E van Montfoort; B Stieger; D K Meijer; H J Weinmann; P J Meier; K E Fattinger
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

6.  Abdominal MR imaging with a volumetric interpolated breath-hold examination.

Authors:  N M Rofsky; V S Lee; G Laub; M A Pollack; G A Krinsky; D Thomasson; M M Ambrosino; J C Weinreb
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

7.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Authors:  B Hamm; T Staks; A Mühler; M Bollow; M Taupitz; T Frenzel; K J Wolf; H J Weinmann; L Lange
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

8.  Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment.

Authors:  Ruth C Carlos; Hero K Hussain; Julie H Song; Isaac R Francis
Journal:  AJR Am J Roentgenol       Date:  2002-07       Impact factor: 3.959

9.  Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.

Authors:  P Reimer; E J Rummeny; K Shamsi; T Balzer; H E Daldrup; B Tombach; T Hesse; T Berns; P E Peters
Journal:  Radiology       Date:  1996-04       Impact factor: 11.105

10.  A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.

Authors:  V M Runge
Journal:  J Comput Assist Tomogr       Date:  1998 Jul-Aug       Impact factor: 1.826

View more
  15 in total

1.  Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard.

Authors:  Eduardo A C Costa; Guilherme M Cunha; Emmanuil Smorodinsky; Irene Cruite; An Tang; Robert M Marks; Lisa Clark; Tanya Wolfson; Anthony Gamst; Jason K Sicklick; Alan Hemming; Michael R Peterson; Michael S Middleton; Claude B Sirlin
Journal:  Radiology       Date:  2015-04-15       Impact factor: 11.105

2.  Added value of gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography for the diagnosis of post-transplant biliary complications.

Authors:  Sonja Kinner; Tilman B Schubert; Adnan Said; Joshua D Mezrich; Scott B Reeder
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

Review 3.  Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.

Authors:  A Agostini; M F Kircher; R Do; A Borgheresi; S Monti; A Giovagnoni; L Mannelli
Journal:  Semin Roentgenol       Date:  2016-05-30       Impact factor: 0.800

Review 4.  Gd-EOB-DTP-enhanced MRC in the preoperative percutaneous management of intra and extrahepatic biliary leakages: does it matter?

Authors:  Mario Petrillo; Anna Maria Ierardi; Laura Tofanelli; Duilia Maresca; Alessio Angileri; Francesca Patella; Gianpaolo Carrafiello
Journal:  Gland Surg       Date:  2019-04

5.  Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.

Authors:  Mustafa R Bashir; Steven R Breault; Ryan Braun; Richard K Do; Rendon C Nelson; Scott B Reeder
Journal:  Acad Radiol       Date:  2014-04-06       Impact factor: 3.173

6.  Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography.

Authors:  Thomas A Hope; Rizwan Aslam; Stefanie Weinstein; Benjamin M Yeh; Carlos U Corvera; Alex Monto; Judy Yee
Journal:  J Comput Assist Tomogr       Date:  2017 May/Jun       Impact factor: 1.826

7.  Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.

Authors:  Peter Bannas; Candice A Bookwalter; Tim Ziemlewicz; Utaroh Motosugi; Alejandro Munoz Del Rio; Theodora A Potretzke; Scott K Nagle; Scott B Reeder
Journal:  Eur Radiol       Date:  2016-04-30       Impact factor: 5.315

8.  Contrast-enhanced free-breathing 3D T1-weighted gradient-echo sequence for hepatobiliary MRI in patients with breath-holding difficulties.

Authors:  C S Reiner; A M Neville; H K Nazeer; S Breault; B M Dale; E M Merkle; M R Bashir
Journal:  Eur Radiol       Date:  2013-06-04       Impact factor: 5.315

9.  Detecting hepatocellular carcinoma in gadoxetic-acid-enhanced hepatobiliary-phase MR imaging at 3T: comparing high and low flip angle.

Authors:  Mina Song; Hyeon Je Cho; Yun Ku Cho; Mi Young Kim; Sang Ik Noh; Soo Hyun Yang
Journal:  Jpn J Radiol       Date:  2013-10-17       Impact factor: 2.374

10.  Free-breathing contrast-enhanced T1-weighted gradient-echo imaging with radial k-space sampling for paediatric abdominopelvic MRI.

Authors:  Hersh Chandarana; Kai T Block; Matthew J Winfeld; Shailee V Lala; Daniel Mazori; Emalyn Giuffrida; James S Babb; Sarah S Milla
Journal:  Eur Radiol       Date:  2013-09-25       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.